NFKB1 and colitis: In conclusion, we successfully constructed a stable EUP-SeNP with good antioxidant capacity in vitro for the first time, which can effectively reduce DSS induced colitis in mice and inhibit the activation of the cellular TRL-4/NF-κB pathway.